Trial Profile
Phase III randomised, double-masked, sham-controlled study of Ozurdex
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Nov 2017
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Retinal vein occlusion
- Focus Therapeutic Use
- Acronyms RVO2
- Sponsors Allergan
- 02 Nov 2017 New trial record